Ozempic does something unexpected to the brain’s hunger neurons
Ozempic may work in the brain in almost the opposite way scientists expected, activating hunger-linked neurons that appear essential for sustaining fat loss. The surprising discovery in mice could reveal new targets for developing even more effective obesity drugs.
Researchers have made a surprising discovery about how Ozempic, a popular medication for obesity, works in the brain. Contrary to expectations, Ozempic activates neurons that are typically associated with hunger, rather than suppressing them. This unexpected finding in mice suggests that these hunger-linked neurons may play a crucial role in sustaining weight loss.
This discovery has significant implications for the development of future obesity treatments. For years, scientists have focused on creating medications that suppress appetite and reduce hunger. However, Ozempic's mechanism of action suggests that targeting hunger neurons in a different way may be more effective in the long run. By understanding how Ozempic interacts with these neurons, researchers may be able to design new treatments that not only help people lose weight but also maintain that weight loss over time.
As the obesity epidemic continues to affect millions of people worldwide, finding more effective treatments is a pressing concern. The next step is to see if these findings can be replicated in humans and if they lead to the development of new, more effective obesity medications. Additionally, researchers will likely investigate how Ozempic's mechanism of action compares to other obesity medications on the market, such as Wegovy and Rybelsus, which are also based on the same active ingredient.
Originally reported by sciencedaily.com. ObesityNews adds analysis for health & wellness readers.